Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.
Epstein-Barr virus (EBV), an oncogenic herpesvirus of humans, displays selective tropism for B lymphocytes and epithelial cells. EBV tropism is thought to be determined in part by a unique host cell receptor termed CR2 (CD21). Although previous studies have demonstrated that CR2 mediates EBV binding...
Guardat en:
| Publicat a: | J Virol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1990
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC249254/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2154612/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.64.3.1348-1352.1990 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
